Revised forecast
Fiscal year ending March 2027 · Full yearPrevious forecast published 13 May 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Life & Healthcare and Electronics performed more strongly than initially expected, and improvements in cost structures across each business and foreign exchange effects also contributed, resulting in higher profit.
| Item | Details |
|---|---|
| Net Sales | 1,530,000 Millions of yen → 1,564,000 Millions of yen（+2.2%） |
| Operating profit | 108,000 Millions of yen → 113,000 Millions of yen（+4.6%） |
| Ordinary income | 124,000 Millions of yen → 134,000 Millions of yen（+8.1%） |
| Profit attributable to owners of the parent | 95,000 Millions of yen → 105,000 Millions of yen（+10.5%） |
| Net income per share | 223.78 Yen/sen → 247.34 Yen/sen |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Full year |
| Publication date of previous forecast | 13 May 2026 |
| Previous-period results | Fiscal year ended March 2026: revenue ¥1,512,571 million, operating income ¥101,039 million, ordinary income ¥119,239 million, net income attributable to owners of the parent ¥103,959 million, earnings per share ¥235.49 |
| Reason for the revision | Life & Healthcare and Electronics performed more strongly than initially expected, and improvements in cost structures across each business and foreign exchange effects also contributed, resulting in higher profit. |
| Dividend forecast revision | The interim dividend was increased by ¥3 per share from the previous forecast of ¥19 to ¥22 per share. The annual dividend is expected to be ¥44. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Life & Healthcare and Electronics performed more strongly than initially expected, while improvements in cost structures across each business and foreign exchange effects also contributed to higher profit. The increase in the interim dividend reflects business progress and the dividend policy.